Development of a Targeted Next-Generation Sequencing assay to Detect Diagnostically Relevant Mutations of JAK2, CALR, and MPL in Myeloproliferative Neoplasms

Researchers developed a next-generation sequencing assay to detect known MPN driver mutations JAK2, CALR, and MPL more quickly and efficiently than classical MPN mutation screening.

 Cancer Cell

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.